Steve Melvyn Howdle
Presidente en The University of Nottingham .
Cargos activos de Steve Melvyn Howdle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of Nottingham | Presidente | - | - |
Historial de carrera de Steve Melvyn Howdle
Antiguos cargos conocidos de Steve Melvyn Howdle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Director Técnico/Científico/I+D | 01/01/2002 | - |
| Fundador | 01/01/2002 | - |
Estadísticas
Internacional
| Reino Unido | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Chairman | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Steve Melvyn Howdle
- Experiencia
